Rejuve Meds review

Rejuve offers several advertised formats, but the selected total, renewal charge and controlling refund terms need a written quote. Its monthly-looking cards describe a twelve-month arrangement rather than an established flexible monthly price.

Rejuve Meds is the consumer name used by Rejuve Inc for a technology and administration platform. Its October 16, 2026 terms say it is neither a medical practice nor a dispensing pharmacy. Independent affiliated practices provide clinical services, and pharmacy partners dispense prescriptions.

The public documents do not name the actual treating practice, clinical network or dispensing pharmacy. The privacy notice says the practice name and clinician will be available in the portal and prescription and can be requested. Ask for those identities before relying on the platform name as the explanation of who provides care. An administrative platform can coordinate access without itself making prescribing decisions. Its representations about licensed partners are not independent verification of those partners' credentials or an individual pharmacy's preparation.

The public offer includes compounded semaglutide and tirzepatide as weekly injections and dissolvable oral tablets. This gives a reader several formats to discuss with a clinician, but the product cards alone do not show which one will be prescribed or whether each preparation is suitable for a particular history. Generic references to brand-name treatment in the cost FAQ do not establish a named brand's availability, price or inclusion. A comparison should begin with the exact proposed medication and formulation rather than assuming every advertised treatment is accessible through the same plan.

The telehealth consent describes questionnaires and messages, with live audio or video if required. A clinician reviews the individual history and may request laboratory work, a live visit or additional information.

The terms require applicants to be at least eighteen and physically present in a service state during consultation. A separate policy limits residents to the fifty United States, but that residency boundary does not prove every product is offered in all fifty states. Confirm eligibility for the state where you will actually receive care. The public material does not resolve precise BMI criteria, exclusions or laboratory requirements and costs. Completing intake or paying is not a guarantee of a prescription.

Rejuve describes ongoing care-team access, while its consent expressly distinguishes that access from continuous monitoring. Ask how to contact the treating clinician, how refill reviews work, and what happens if a concern arises between scheduled interactions. The terms say the price includes a clinician-consultation portion, without establishing a separately itemized consultation fee. That distinction matters because refund language may treat the medication and service components differently.

Rejuve does not bill insurance; HSA or FSA use depends on the plan administrator, and financing depends on lender terms. A displayed eligibility badge does not settle reimbursement for an individual purchase.

Four homepage cards advertise monthly equivalents attached to a twelve-month plan paid upfront or through buy-now-pay-later financing: semaglutide injections $165, tirzepatide injections $265, semaglutide dissolvable tablets $195 and tirzepatide dissolvable tablets $295. These are not verified month-to-month charges. Neither the full contractual total nor the amount due immediately was established, so multiplying the card amounts into an assumed obligation would overstate what is known.

The hero advertises an $85 start, while the expanded cost FAQ describes an $85 promotional first month followed by $205–$399 depending on medication. Early Summer Special and New Year promotion labels coexist with $120-off first-month wording. Those inconsistent offers do not establish which promotion applies to a selected order. Ask for one itemized quote covering initial charge, supply, plan term, installment schedule, renewal price and any shipping or laboratory amount.

No membership fees does not mean no recurring medication payments: the October terms authorize refill charges at the cadence selected at checkout until cancellation. Examples include every four weeks or a new three-, six- or twelve-month term. They promise a reminder at least three days before charging, fixed pricing during the term regardless of dose and thirty days notice of price changes. None of these general rules establishes the exact renewal amount for a specific card.

The homepage advertises free delivery, but the terms allow any shipping charge to be shown at checkout. Resolve that discrepancy in the written quote.

The October terms allow cancellation of future refills before charging through the portal's Account, Manage plan and Cancel controls, or by telephone or the listed support contact, with confirmation promised. They describe refunds for prepaid unshipped months after adjusting discounts on shipped months, medication-portion refunds before pharmacy submission, and a full refund if the clinician declines treatment. Approved refunds typically take five to ten business days.

The separate refund-and-cancellation policy is materially stricter: it says prescription orders become nonrefundable when initial intake is submitted, processed subscription charges are nonrefundable, and cancellation generally stops future charges only. It says a full refund may be granted for initial clinical ineligibility, subject to truthful disclosure, or a verified billing error, with written requests within twenty-eight days of payment. Do not assume the newer terms automatically control every order. Request the applicable agreement, refund components and unused-month calculation before paying.

Processing is described as two to three business days after approval, with average delivery shipping of four to twelve business days; these are estimates, not arrival guarantees. The terms ask that lost, damaged or warm orders be reported within seven days of expected delivery, with packaging retained for verification before a promised no-cost replacement.

Compounded medicines are not FDA approved or established generic versions of named brands. Oral cards do not demonstrate equivalence to injections or establish formulation-specific effectiveness. Ask the prescriber about the exact preparation, quantity and storage requirements rather than treating convenience or seller outcomes as clinical evidence.